A novel action of minocycline: Inhibition of human immunodeficiency virus type 1 infection in microglia

Journal of NeuroVirology

Volumn 10, Issue 5, 2004, Pages 284-292

  Si, Qiusheng ^a   Cosenza, Melissa A ^a   Kim, Mee Ohk ^a   Zhao, Meng Liang ^a   Brownlee, Michael ^a   Goldstein, Harris ^a   Lee, Sunhee C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; Dementia; HIV; Inflammation; Microglia; NF B; Tetracycline

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MINOCYCLINE; TETRACYCLINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EXPOSURE; DRUG PENETRATION; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVATION; ENZYME INHIBITION; FETUS; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VIVO STUDY; LONG TERMINAL REPEAT; MICROGLIA; PRIORITY JOURNAL; PROMOTER REGION; VIRUS INHIBITION;

CELL CULTURE TECHNIQUES; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MICROGLIA; MINOCYCLINE; NF-KAPPA B; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 7244257593     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280490499533     Document Type: Article

References (59)

1. Albright AV, Shieh JTC, Itoh T, Lee B, Pleasure D, O'Connor MJ, Doms RW, Gonzalez-Scarano F (1999). Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73: 205-213.
2. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB (1996). A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 93: 14014-14019.
3. Andersson PB, Perry VH, Gordon S (1992). Intracerebral injection of proinflammtory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 176: 255-259.
4. Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov S, Johnson PF (1998). Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol 18: 5678-5689.
5. Barza M, Brown RB, Shanks C, Gamble C, Weinstein L (1975). Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother 8: 713-720.
6. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW (2002). Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis. Brain 125: 1297-1308.
7. Budka H (1990). Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 79: 611-619.
8. Canki M, Thai JN, Chao W, Ghorpade A, Potash MJ, Volsky DJ (2001). Highly productive infection with pseudo-typed human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol 75: 7925-7933.
9. Chen MC, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM (2000). Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6: 797-801.
10. Cosenza M, Zhao M-L, Si Q, Lee SC (2002). Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12: 442-455.
11. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkjart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
12. Di Marzio P, Mariani R, Lui R, Thomas EK, Landau NR (2000). Soluble CD40 ligand induces β-chemokine production by macrophages and resistance to HIV-1 entry. Cytokine 12: 1489-1495.
13. Dickson DW, Lee SC, Hatch WC, Mattiace L, Brosnan CF, Lyman WD (1994). Macrophages and microglia in HIV-1-related CNS neuropathology. In HIV, AIDS and the brain, ARNMD. Price RW, Perry SW (eds). New York: Raven Press, pp 99-118.
14. Dickson DW, Lee SC, Mattiace L, Yen S-H, Brosnan CF (1993). Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75-83.
15. Downen M, Amaral TD, Hua LL, Zhao ML, Lee SC (1999). Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 28: 114-127.
16. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
17. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM (2001). Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 98: 14669-14674.
18. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O (2003). Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 100: 13632-13637.
19. Felber BK, Pavlakis GN (1988). A quantitative bioassay for HIV-1 based on trans-activation. Science 239: 184-187.
20. Gabler WL, Creamer HR (1991). Supression of human neutrophil functions by tetracyclines. J Periodontal Res 26: 52-58.
21. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantification of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762.
22. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS (1983). Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res 18: 516-526.
23. Gonzalez-Scarano F, Baltuch G (1999). Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219-240.
24. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645-649.
25. Hua LL, Kim MO, Brosnan CF, Lee SC (2002). Modulation of astrocyte inducible nitric oxide synthase and cytokine expression by IFN is associated with induction and inhibition of GAS binding activity. J Neurochem 83: 1120-1128.
26. Kim MO, Si Q, Zhou JN, Pestell RG, Brosnan CF, Locker J, Lee SC (2002). Interferon-beta activates multiple signaling cascades in primary human microglia. J Neurochem 81: 1361-1371.
27. Kolson DL, Lavi E, Gonzalez-Scarano F (1998). The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res 50: 1-47.
28. Lambotte O, Taoufik Y, de Goer MG, Wallon C, Goujard C, Delfraissy JF (2000). Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr 23: 114-119.
29. Langevitz P, Livneh A, Bank I, Pras M (2000). Benefits and risks of minocycline in rheumatoid arthritis. Drug Saf 22: 405-414.
30. Lee SC, Hatch WC, Liu W, Lyman WD, Kress Y, Dickson DW (1993a). Productive infection of human fetal microglia by HIV-1. Am J Pathol 143: 1032-1039.
31. Lee SC, Liu W, Brosnan CF, Dickson DW (1992). Characterization of human fetal dissociated CNS cultures with an emphasis on microglia. Lab Invest 67: 465-475.
32. Lee SC, Liu W, Brosnan CF, Dickson DW (1994). GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12: 309-318.
33. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW (1993b). Cytokine production by human fetal microglia and astrocytes: differential induction by LPS and IL-1β. J Immunol 150: 2659-2667.
34. Lewin SR, Lambert P, Deacon NJ, Mills J, Crowe SM (1997). Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages. J Virol 71: 2114-2119.
35. Lipton SA (1998). Neuronal injury associated with HIV-1: approaches to treatment. Annu Rev Pharmacol Toxicol 38: 159-177.
36. Lipton SA, Gendelman HE (1995). Dementia associated with the acquired immunodeficiency syndrome. New Engl J Med 332: 934-940.
37. Liu JSH, John GR, Sikora A, Lee SC, Brosnan CF (2000). Modulation of IL-1β and TNFα signaling by P2 purinergic receptors in human fetal astrocytes. J Neurosci 20: 5292-5299.
38. Mahlknecht U, Deng C, Lu MC, Greenough TC, Sullivan JL, O'Brien WA, Herbein G (2000). Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence. J Immunol 165: 6437-6446.
39. Mahlknecht U, Herbein G (2001). Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells? Trends Immunol 22: 256-260.
40. Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IRS (1992). Induction of interleukin-1 and tumor necrosis factor α in brain cultures by human immunodeficiency virus type 1. J Virol 66: 2217-2225.
41. Navia BA, Jordan BD, Price RW (1986). The AIDS dementia complex. I. Clinical features. Ann Neurol 19: 517-524.
42. Olson WC, Rabut GE, Nagashima KA, Tran DN, Anselma DJ, Monard SP, Segal JP, Thompson DA, Kajumo F, Guo Y, Moore JP, Maddon PJ, Dragic T (1999). Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J Virol 73: 4145-4155.
43. Popovic N, Schubart A, Goetz BD, Zhang SC, Linington C, Duncan ID (2002). Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51: 215-223.
44. Rabson AB, Lin H-C (2000). NF-κB and HIV: linking viral and immune activation. In HIV-1: molecular biology and pathogenesis. Jeang K-T (ed). New York: Academic Press, pp 161-195.
45. Scholzen T, Gerdes J (2000). The Ki-67 protein: from the known to the unknown. J Cell Physiol 182: 311-322.
46. Sharkey ME, Teo I, Greenough T, Sharova N, Luzuriaga K, Sullivan JL, Bucy RP, Kostrikis LG, Haase A, Veryard C, Davaro RE, Cheeseman SH, Daly JS, Bova C, Ellison RT III, Mady B, Lai KK, Moyle G, Nelson M, Gazzard B, Shaunak S, Stevenson M (2000). Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 6: 76-81.
47. Si Q, Cosenza M, Zhao M-L, Goldstein H, Lee SC (2002). GM-CSF and M-CSF modulate β-chemokine and HIV-1 expression in microglia. Glia 39: 174-183.
48. Sonza S, Mutimer HP, Oelrichs R, Jardine D, Harvey K, Dunne A, Purcell DF, Birch C, Crowe SM (2001). Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 15: 17-22.
49. Stevenson M, Gendelman HE (1994). Cellular and viral determinants that regulate HIV-1 infection in macrophages. J Leukoc Biol 56: 278-288.
50. Swingler S, Mann A, Jacque J, Brichacek B, Sasseville VG, Williams K, Lackner AA, Janoff EN, Wang R, Fisher D, Stevenson M (1999). HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 5: 997-1003.
51. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705-711.
52. Tamargo RJ, Bok RA, Brem H (1991). Angiogenesis inhibition by minocycline. Cancer Res 51: 672-675.
53. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM (2004). Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 101: 3071-3076.
54. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588.
55. Tornatore C, Chandra R, Berger JR, Major EO (1994). HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44: 481-487.
56. Tyor WR, Glass JD, Griffin JW, Becker PS, McArther JC, Bezman L, Griffin DE (1992). Cytokine expression in the brain during AIDS. Ann Neurol 31: 349-360.
57. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999). A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96: 13496-13500.
58. Zhang SC, Goetz BD, Duncan ID (2003). Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors. Glia 41: 191-198.
59. Zhao ML, Kim MO, Morgello S, Lee SC (2001). Expression of iNOS, IL-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol 115: 182-191.